How has been the historical performance of Vanta Bioscience?

Answer:The historical performance of Vanta Bioscience shows fluctuations in net sales and profitability over the years, with a notable decline in recent periods.

Breakdown:
Vanta Bioscience's net sales have varied significantly from Mar'18 to Mar'24, starting at 3.99 Cr in Mar'18, peaking at 14.14 Cr in Mar'20, and then declining to 9.72 Cr in Mar'24. The total operating income followed a similar trend, with a high of 14.14 Cr in Mar'20 and a drop to 9.72 Cr in Mar'24. The company's operating profit (PBDIT) was positive in several years, reaching 4.48 Cr in Mar'20, but turned negative in Mar'23 at -1.70 Cr and improved slightly to 1.42 Cr in Mar'24. However, the profit before tax remained negative in Mar'24 at -2.54 Cr, although it improved from -6.30 Cr in Mar'23. The net profit also reflected this trend, with losses of -2.32 Cr in Mar'24 and -6.48 Cr in Mar'23, contrasting with a profit of 0.09 Cr in Mar'22. The company's total liabilities increased from 39.00 Cr in Mar'19 to 85.40 Cr in Mar'24, while total assets rose from 39.00 Cr in Mar'19 to 85.40 Cr in Mar'24, indicating a growing but potentially concerning leverage. Cash flow from operating activities showed a positive trend in Mar'24 at 2.00 Cr, compared to 0.00 Cr in Mar'23, but cash flow from investing activities remained negative. Overall, Vanta Bioscience has faced challenges in maintaining profitability while experiencing growth in sales and total assets.